Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy ; volume:55 ; number:9 ; day:11 ; month:9 ; year:2023 ; pages:1913-1921 ; date:9.2023
Experimental & molecular medicine ; 55, Heft 9 (11.9.2023), 1913-1921, 9.2023
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-023-01075-0
- URN
-
urn:nbn:de:101:1-2023122515131528652200
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Joon Seok
- Gazzaniga, Francesca S.
- Kasper, Dennis L.
- Sharpe, Arlene H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exploiting innate immunity for cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Codevelopment of microbiota and innate immunity and the risk for Group B streptococcal disease
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Regulation of innate receptor pathways by microRNAs
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Intestinal microbiota: a new force in cancer immunotherapy
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
Exploiting innate immunity for cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Codevelopment of microbiota and innate immunity and the risk for Group B streptococcal disease
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Regulation of innate receptor pathways by microRNAs
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Intestinal microbiota: a new force in cancer immunotherapy
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
Exploiting innate immunity for cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Codevelopment of microbiota and innate immunity and the risk for Group B streptococcal disease
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Regulation of innate receptor pathways by microRNAs
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Intestinal microbiota: a new force in cancer immunotherapy